Page last updated: 2024-10-25

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Degenerative Diseases, Central Nervous System

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone: ubiquinol analog
6-decylubiquinone : A member of the class of 1,4-benzoquinones that is 2,3-dimethoxybenzoquinone which has been substituted at positions 5 and 6 by decyl and methyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldschmidt, R1
Arce, PM1
Khdour, OM1
Collin, VC1
Dey, S1
Jaruvangsanti, J1
Fash, DM1
Hecht, SM1
Telford, JE1
Kilbride, SM1
Davey, GP1

Other Studies

2 other studies available for 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Degenerative Diseases, Central Nervous System

ArticleYear
Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases.
    Bioorganic & medicinal chemistry, 2013, Feb-15, Volume: 21, Issue:4

    Topics: Adenosine Triphosphate; Animals; Antioxidants; Cattle; Cell Line; Cell Survival; Drug Design; Glutat

2013
Decylubiquinone increases mitochondrial function in synaptosomes.
    The Journal of biological chemistry, 2010, Mar-19, Volume: 285, Issue:12

    Topics: Animals; Antimycin A; Electron Transport; Female; Methacrylates; Mitochondria; Models, Biological; N

2010